ADR | Frequency |
Serum creatinine | Baseline and at least monthly while receiving an injectable drug. |
Serum potassium | At least monthly while receiving an injectable agent particularly those receiving capreomycin. |
Thyroid stimulating hormone(TSH) | Baseline. Ideally, once between months 6 and 9 of treatment, if receiving ethionamide and/or PAS. Monitor for signs/symptoms of hypothyroidism. |
Liver serum enzymes | Consider periodic monitoring in patients receiving pyrazinamide for extended periods of time or for patients at risk of hepatitis. |